The announcement of the launch of Dewpoint Therapeutics, with $60 Million Series A funding has received significant attention from media and analysts. Read a selection of the key coverage via the links below.
Read more on bioworld.com
Read more on european-biotechnology.com
Read more on fiercebiotech.com
Read more on xconomy.com
Read more on wsj.com
Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science